FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

1514151000168100: Australian Black Triangle Scheme reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Dec 2020. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4501271000168110 Australian Black Triangle Scheme reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4501281000168113 Australian Black Triangle Scheme reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4501291000168111 Black Triangle Scheme reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4501301000168112 BTS (Black Triangle Scheme) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4501421000168113 <p>Supports the identification of AMT TPUU and CTPP concepts that are associated with medicines where reporting adverse events are encouraged under the Black Triangle Scheme. </p><p>This reference set can be used by prescribing and dispensing software vendors to identify medications where reporting of adverse events is encouraged under the Black Triangle Scheme.</p><p><span><b>Target client</b>: This reference set was developed by the National Clinical Terminology Service, based on information from the Therapeutic Goods Administration (TGA), to support the reporting of adverse events, and can be used by developers to assist with the identification of medicines associated with the Black Triangle Scheme.</span><br></p> en Definition Active Case sensitive Australian Medicines Terminology module


1411 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Black Triangle Scheme reference set Is a Reference sets for Medications true Inferred relationship Some
Black Triangle Scheme reference set Is a Simple type reference set true Inferred relationship Some
Black Triangle Scheme reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 494774926
Black Triangle Scheme reference set Developed by Australian Digital Health Agency true Inferred relationship Some 254185599

Members
Lurasidone (Sandoz) 40 mg tablet
Lurasidone (Sandoz) 40 mg tablet, 28, blister pack
Lurasidone (Sandoz) 40 mg tablet, 30, blister pack
Lurasidone (Sandoz) 80 mg tablet
Lurasidone (Sandoz) 80 mg tablet, 28, blister pack
Lurasidone (Sandoz) 80 mg tablet, 30, blister pack
Lurobi 20 mg tablet
Lurobi 20 mg tablet, 28, blister pack
Lurobi 20 mg tablet, 30, blister pack
Lurobi 40 mg tablet
Lurobi 40 mg tablet, 28, blister pack
Lurobi 40 mg tablet, 30, blister pack
Lurobi 80 mg tablet
Lurobi 80 mg tablet, 28, blister pack
Lurobi 80 mg tablet, 30, blister pack
Luxturna (1 x 0.5 mL vial, 2 x 1.7 mL inert diluent vials), 1 pack
Luxturna (inert substance) diluent, 1.7 mL vial
Luxturna (voretigene neparvovec 5 trillion vector genomes/mL) injection, 0.5 mL vial
Maviret tablet
Maviret tablet, 84, blister pack
Maviret tablet, 84, bottle
Mayzent 2 mg tablet
Mayzent 2 mg tablet, 28, blister pack
Mayzent 250 microgram tablet
Mayzent 250 microgram tablet, 12, blister pack
Mayzent 250 microgram tablet, 120, blister pack
Mektovi 15 mg tablet
Mektovi 15 mg tablet, 84, blister pack
Menquadfi injection, 0.5 mL vial
Menquadfi injection, 0.5 mL vial
Menquadfi injection, 10 x 0.5 mL vials
Midodrine (ANS) 2.5 mg tablet
Midodrine (ANS) 2.5 mg tablet, 500, blister pack
Midodrine (ANS) 2.5 mg tablet, 60, blister pack
Midodrine (ANS) 2.5 mg tablet, 90, blister pack
Midodrine (ANS) 5 mg tablet
Midodrine (ANS) 5 mg tablet, 500, blister pack
Midodrine (ANS) 5 mg tablet, 60, blister pack
Midodrine (ANS) 5 mg tablet, 90, blister pack
Midodrine (SCP) 2.5 mg tablet
Midodrine (SCP) 2.5 mg tablet, 500, blister pack
Midodrine (SCP) 2.5 mg tablet, 60, blister pack
Midodrine (SCP) 2.5 mg tablet, 90, blister pack
Midodrine (SCP) 5 mg tablet
Midodrine (SCP) 5 mg tablet, 500, blister pack
Midodrine (SCP) 5 mg tablet, 60, blister pack
Midodrine (SCP) 5 mg tablet, 90, blister pack
Mounjaro 10 mg/0.5 mL injection, 0.5 mL pen device
Mounjaro 10 mg/0.5 mL injection, 2 x 0.5 mL pen devices
Mounjaro 10 mg/0.5 mL injection, 4 x 0.5 mL pen devices
Mounjaro 12.5 mg/0.5 mL injection, 0.5 mL pen device
Mounjaro 12.5 mg/0.5 mL injection, 2 x 0.5 mL pen devices
Mounjaro 12.5 mg/0.5 mL injection, 4 x 0.5 mL pen devices
Mounjaro 15 mg/0.5 mL injection, 0.5 mL pen device
Mounjaro 15 mg/0.5 mL injection, 2 x 0.5 mL pen devices
Mounjaro 15 mg/0.5 mL injection, 4 x 0.5 mL pen devices
Mounjaro 2.5 mg/0.5 mL injection, 0.5 mL pen device
Mounjaro 2.5 mg/0.5 mL injection, 2 x 0.5 mL pen devices
Mounjaro 2.5 mg/0.5 mL injection, 4 x 0.5 mL pen devices
Mounjaro 5 mg/0.5 mL injection, 0.5 mL pen device
Mounjaro 5 mg/0.5 mL injection, 2 x 0.5 mL pen devices
Mounjaro 5 mg/0.5 mL injection, 4 x 0.5 mL pen devices
Mounjaro 7.5 mg/0.5 mL injection, 0.5 mL pen device
Mounjaro 7.5 mg/0.5 mL injection, 2 x 0.5 mL pen devices
Mounjaro 7.5 mg/0.5 mL injection, 4 x 0.5 mL pen devices
Mylotarg 5 mg powder for injection, 1 vial
Mylotarg 5 mg powder for injection, 5 mg vial
Nerlynx 40 mg tablet
Nerlynx 40 mg tablet, 133, bottle
Nerlynx 40 mg tablet, 180, bottle
Nextstellis (estetrol 14.2 mg + drospirenone 3 mg) tablet
Nextstellis (24 x 14.2 mg/3 mg tablets, 4 x inert tablets), 28, blister pack
Nextstellis (24 x 14.2 mg/3 mg tablets, 4 x inert tablets), 3 x 28, blister packs
Nextstellis (24 x 14.2 mg/3 mg tablets, 4 x inert tablets), 6 x 28, blister packs
Nexviazyme 100 mg/10 mL powder for injection, 10 mL vial
Nexviazyme 100 mg/10 mL powder for injection, 10 mL vial
Nexviazyme 100 mg/10 mL powder for injection, 10 x 10 mL vials
Nexviazyme 100 mg/10 mL powder for injection, 25 x 10 mL vials
Nexviazyme 100 mg/10 mL powder for injection, 5 x 10 mL vials
Ngenla 24 mg/1.2 mL injection, 1.2 mL pen device
Ngenla 24 mg/1.2 mL injection, 1.2 mL pen device
Ngenla 60 mg/1.2 mL injection, 1.2 mL pen device
Ngenla 60 mg/1.2 mL injection, 1.2 mL pen device
Nubeqa 300 mg tablet
Nubeqa 300 mg tablet, 112, blister pack
Nubeqa 300 mg tablet, 120, bottle
Nuceiva 100 units powder for injection, 1 vial
Nuceiva 100 units powder for injection, 100 units vial
Nuvaxovid Multidose injection, 10 x 5 mL vials
Nuvaxovid Multidose injection, 5 mL vial
Ocaliva (obeticholic acid 10 mg) tablet (trade product unit of use)
Ocaliva (obeticholic acid 10 mg) tablet, 100 tablets, bottle (containered trade product pack)
Ocaliva 10 mg tablet, 30, bottle
Ocaliva 5 mg tablet
Ocaliva 5 mg tablet, 100, bottle
Ocaliva 5 mg tablet, 30, bottle
Olumiant 2 mg tablet
Olumiant 2 mg tablet, 28, blister pack
Olumiant 2 mg tablet, 7, blister pack
Olumiant 4 mg tablet
Olumiant 4 mg tablet, 28, blister pack

Start Previous Page 9 of 15 Next End


Reference Sets

Reference set descriptor

Back to Start